Cardiovascular

9 articles tagged “Cardiovascular”

Learn

Perimenopause Heart Risk: AHA 9,248-Woman Window Study

New AHA analysis of 9,248 women shows perimenopausal women are 2x more likely to have low cardiovascular health. What to test and when to act.

When to Start HRT in Menopause: Timing Hypothesis

Why HRT started within 10 years of menopause cuts mortality 39% and CVD risk 50%, but late starts can backfire. The timing-hypothesis evidence.

Testosterone Therapy CV Safety in Women: 2026 Review

Feb 2026 systematic review of 2,628 women on testosterone: zero cardiovascular deaths in trials. What the data actually says — and where the gaps are.

European TRT Verdict: AFib Signal, Heart Safety

Europe's testosterone expert panel issued its 2026 TRAVERSE verdict. Heart attacks reassuring, atrial fibrillation signal real. What changes for you.

TRT, Heart Risk, and Prostate Cancer: 41-Trial Review

A new 2026 meta-analysis pooled 41 RCTs and 11,161 men. Here's what it actually says about TRT, heart attacks, strokes, and prostate cancer.

Heart Palpitations in Perimenopause: Causes & HRT Fix

Up to 54% of perimenopausal women get heart palpitations. Here's what causes them, when to worry, and how HRT stops the racing-heart feeling fast.

TRT and Heart Risk: TRAVERSE Trial Explained

The TRAVERSE trial studied 5,246 men on TRT for cardiovascular safety. Here's what the landmark study found and why the FDA removed its heart warning.

Protocols & Results

TRT and Cholesterol: HDL, LDL, and Triglyceride Changes

What TRAVERSE, IPD meta-analyses, and clinical guidelines show about lipid changes on testosterone therapy — and how disciplined clinics monitor it.

TRT and Blood Pressure: What the Data Shows

What TRAVERSE, ambulatory BP studies, and the FDA's 2025 label change show about TRT and blood pressure — plus how disciplined clinics monitor it.